Huasun Technology: The listing transfer of 51% equity in Tibet Kangyu has its reserve price adjusted to 52 million yuan

Huasun announced that the company is publicly listing the transfer of 51% equity in its controlling subsidiary, Tibet Kangyu Pharmaceutical Co., Ltd., with an initial listing price of RMB 63.7806 million. However, due to the lack of qualified interested buyers, the company has decided to adjust the listing price to RMB 52 million and will relist at the Southwest United Property Rights Exchange. This transaction is a public listing transfer, and the transaction counterpart and price are still uncertain, posing significant uncertainty and investment risks. If the transaction is successfully implemented, the company will fulfill its information disclosure obligations in a timely manner based on the progress